AHA: Low Bleeding Rates Observed in Dabigitran Dose-Ranging Trial (CME/CE)

ORLANDO (MedPage Today) The oral anti-coagulant dabigatran did not appear to markedly increase major bleeding rates among post-MI patients who were already being treated with aspirin and clopidogrel (Plavix), researchers said here.

source : www.medpagetoday.com

Related News:

• AAPM: Capsaicin Patch Unaffected by Anesthestics (CME/CE)
• AAPM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AAPM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• HRT Linked to Asthma Risk (CME/CE)
• AM: Facet Graft Quells Refractory Back Pain (CME/CE)
• AM: Spine Stimulation Leads to Durable Pain Relief (CME/CE)
• AM: Botox May Relieve Postherpetic Neuralgia (CME/CE)
• AM: Drug for Fibromyalgia Boosts Multiple Outcomes (CME/CE)
• AM: Help for Pain and Mood in Fibromyalgia (CME/CE)
• Older Women with Gout at Risk of MI (CME/CE)

Details :
Submited at Thursday, November 19th, 2009 at 1:00 pm on Cardiology by robert
Comment RSS 2.0 - leave a comment - trackback